The Journal of Heart and Lung Transplantation
Volume 26, Issue 10 , Pages 1061-1064 , October 2007

Treatment of Unprotected Left Main Coronary Artery Stenosis in a 5-Year-Old Heart Transplant Patient Using a Sirolimus-Eluting Stent

  • Joseph G. Salloum, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Vanderbilt University, Nashville, Tennessee
    • Corresponding Author InformationReprint requests: Joseph G. Salloum, MD, Vanderbilt University, Medicine/Cardiology, 2220 Pierce Ave, 383 PRB, Nashville, TN 37232. Telephone: 1-615-327-4751; Fax: 1-615-321-6326
    • ,
  • Debra A. Dodd, MD

      Affiliations

    • Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee.
    • ,
  • David Slosky, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Vanderbilt University, Nashville, Tennessee
    • ,
  • David X.M. Zhao, MD

      Affiliations

    • Division of Cardiology, Department of Internal Medicine, Vanderbilt University, Nashville, Tennessee

Received 18 February 2007 ,Revised 8 July 2007 ,Accepted 15 July 2007.

References 

  1. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart and lung transplantation report. Journal of Heart and Lung Transplantation. 2006;25:893–903
  2. Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection reduces acute rejection and vasculopathy in cardiac transplant recipients. N Engl J Med. 2003;349:847–858
  3. Boucek MM, Sondheimer HM, Ivy DD, et al. Transplant coronary artery disease in pediatrics: favorable outcome with medical therapy. J Heart Lung Transplant. 2001;20:261;[Abstract]
  4. Batchelor WB, Mahaffey KW, Berger PB, et al. A randomized, placebo controlled trial of enoxaparin after high risk coronary stenting: the ATLAST trial. J Am Coll Cardiol. 2001;38:1608–1613
  5. Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947–952
  6. Keogh A, Valantine H, Hunt S, et al. Impact of proximal or mid vessel discrete coronary artery stenosis on survival after heart transplantation. J Heart Lung Transplant. 1992;11:892–901
  7. Musci M, Loebe M, Wellnhofer E, et al. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease. Thorac Cardiovasc Surg. 1998;46:268–274
  8. Halle AA, DiSciascio G, Massin EK. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Cardiol. 1995;26:120–128
  9. Srivastava R, Keck BM, Bennett LE, Hosenpud JD. The results of cardiac retransplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Transplantation. 2000;70:606–612
  10. Benza RL, Zoghbi GJ, Tallaj J, et al. Palliation of allograft vasculopathy with transluminal angioplasty. J Am Coll Cardiol. 2004;43:1973–1981
  11. Kobashigawa J, Wener L, Johnson J, et al. Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. J Heart Lung Transplant. 2000;19:546–550
  12. Tanaka K, Li H, Curran PJ, Takano Y. Usefulness and safety of percutaneous coronary interventions for cardiac transplant vasculopathy. Am J Cardiol. 2006;97:1192–1197
  13. Hognestad A, Endresen K, Wergeland R, et al. : Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis. J Heart Lung Transplant. 2005;24:1026–1032
  14. Jonas M, Fang JC, Wang JC, et al. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol. 2006;48:453–461
  15. Bader F, Kfoury AG, Gilbert EM, et al. Percutaneous coronary interventions with stents in cardiac transplant recipients. J Heart Lung Transplant. 2006;25:298–301
  16. Aranda JM, Pauly DF, Kerensky RA, et al. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy: one center’s experience. J Heart Lung Transplant. 2002;21:860–866

PII: S1053-2498(07)00533-5

doi: 10.1016/j.healun.2007.07.020

The Journal of Heart and Lung Transplantation
Volume 26, Issue 10 , Pages 1061-1064 , October 2007

Article Tools

* Image Usage & Resolution